Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.56387 | 23 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.51348 | 22 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.51377 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.45121 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.47654 | 22 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.56527 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.54949 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.48694 | 21 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.47645 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.4992 | 22 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.49881 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.48648 | 22 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.50555 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.50215 | 22 |